| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 03/24/2009 | US7507824 Spiro(2H-1benzopyran-2,4′-piperidine) derivates as glycine transport inhibitors |
| 03/24/2009 | US7507822 Cyclizing, halogenating by reacting in presence of catalytic amount of metal halide and dehydrating agent |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507752 A C9-deoxomeridamycin, used as a neuroregenerative agent |
| 03/24/2009 | US7507746 Enantiomer of tenatoprazole and the use thereof in therapy |
| 03/24/2009 | US7507744 Spiroazabicyclic heterocyclic compounds |
| 03/24/2009 | US7507545 Ion channel modulating activity method |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/19/2009 | WO2009035668A1 Facile assembly of fused benzofuro-heterocycles |
| 03/19/2009 | WO2009035652A1 Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
| 03/19/2009 | WO2009034061A1 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter |
| 03/19/2009 | WO2009033581A1 Substituted tricyclic compounds and methods of use thereof |
| 03/19/2009 | US20090076268 Facile assembly of fused benzofuro-heterocycles |
| 03/19/2009 | US20090076099 Deuterium-enriched ixabepilone |
| 03/19/2009 | US20090076059 Deuterium-enriched dianicline |
| 03/19/2009 | US20090075995 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 03/19/2009 | CA2698808A1 Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
| 03/18/2009 | EP2036908A2 Efficient synthesis of pyropheophorbide a derivates |
| 03/18/2009 | EP2036898A2 Method for manufacturing 1.3 dioxolane 2ones and carboxylic acid esters by transacylation under alkaline reaction conditions |
| 03/18/2009 | EP2035429A1 FUSED [d]PYRIDAZIN-7-ONES |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | CN101389632A Spiroketals |
| 03/18/2009 | CN101389600A Optical isomers of dihydro-2,3-benzodiazepine derivatives, process for their stereoselective synthesis |
| 03/18/2009 | CN101389332A Preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemia reperfusion in stroke |
| 03/18/2009 | CN101386591A Lamellarins alkaloid and and preparation method and use in anti-hiv thereof |
| 03/18/2009 | CN100469780C Cysteine protease inhibitors |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/17/2009 | US7504507 carboxamide linked compounds based on benzo[b][1,6]naphthyridin-1 (2H)-one, which differ from previous acridine based compounds by the incorporation of a lactam or thiolactam function in one of the outer rings |
| 03/17/2009 | US7504506 Therapeutic compounds and uses thereof |
| 03/17/2009 | US7504496 Water-soluble rhodamine dye conjugates |
| 03/17/2009 | US7504436 Bioisosteres of actinonin |
| 03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504371 Organic catalyst with enhanced enzyme compatibility |
| 03/17/2009 | US7504360 Containing crystalline compounds which produce color when thermally converted to liquid or amorphous form time-independent |
| 03/12/2009 | WO2009032754A2 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| 03/12/2009 | WO2009032123A2 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 03/12/2009 | WO2009011617A3 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 03/12/2009 | WO2007092681A3 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 03/12/2009 | US20090069401 Marine actinomycete taxon for drug and fermentation product discovery |
| 03/12/2009 | US20090069393 Parenteral formulation for epothilone analogs |
| 03/12/2009 | US20090069366 Deuterium-enriched tacrolimus |
| 03/12/2009 | US20090068751 Methods of Labelling Polynucleotides with Dibenzorhodamine Dyes |
| 03/12/2009 | CA2698511A1 Substituted pyrimidinyl-amines as protein kinase inhibitors |
| 03/12/2009 | CA2697451A1 Tetracyclic indole derivatives and methods of use thereof |
| 03/11/2009 | EP2033959A1 Tetrahydropyranoquinoline derivatives |
| 03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
| 03/11/2009 | EP2032581A2 Polymorphic forms and process |
| 03/11/2009 | EP2032535A1 Spirocyclic nitriles as protease inhibitors |
| 03/11/2009 | EP1667770B1 Method for the production of derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro [3a,3,2][ 2]- benzazepine |
| 03/11/2009 | EP1581526B1 Benzisoxazole derivatives useful as inhibitors of protein kinases |
| 03/11/2009 | EP1480984B9 Hexacyclic compounds |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1319659B1 Triazinones and medicinal use thereof |
| 03/11/2009 | EP1317445B1 Chemokine receptor binding heterocyclic compounds |
| 03/11/2009 | CN101384603A Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 03/11/2009 | CN101384602A Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 03/11/2009 | CN101384583A Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 03/11/2009 | CN101381345A Tetrahydroquinoline derivatives and a process for preparing the same |
| 03/10/2009 | US7501525 Derivatives of benzimidazole and their use as medicaments |
| 03/10/2009 | US7501524 Melacocortin receptors; analgesics; antiinflammatory agents; eating disorders; psychological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
| 03/10/2009 | US7501438 1-(3-naphthalen-1-yl-imidazo[1,5-a]pyridin-1-yl)-butan-1-one; chronic pain, an inflammatory disorder, rheumatoid arthritis, multiple sclerosis, osteoporosis and osteoarthritis; cannabinoid receptor ligands |
| 03/10/2009 | US7501429 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
| 03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 03/10/2009 | CA2285263C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 03/05/2009 | WO2009028899A1 1'-alkylpiperidine-4'-spiro-2-6-(amido)-2h-benzopyran derivatives having anticancer activity |
| 03/05/2009 | WO2009028618A1 Piperidine derivative |
| 03/05/2009 | WO2009026961A1 Processes for the preparation of pancratistatin and pancratistatin analogues |
| 03/05/2009 | WO2009026934A1 Catecholamine derivatives useful for the treatment of parkinson' s disease |
| 03/05/2009 | WO2008157291A3 CRYSTALLINE FORMS OF (3Aα, 4β, 5α, 7β, 7Aα)-4-(OCTAHYDRO-5-ETHYLSULFONAMIDO-4,7-DIMETHYL-1,3-DIOXO-4,7-EPOXY-2H-ISOINDOL-2-YL)-2-(TRIFLUOROMETHYL)BENZONITRILE AND METHOD OF PREPARATION |
| 03/05/2009 | WO2008127274A3 Heterocyclic inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 03/05/2009 | WO2005121138A3 Heterotricyclic compounds for use as hcv inhibitors |
| 03/05/2009 | US20090062533 5-hydroxy-7H-benzo[C]fluorene derivatives: 7,7-dimethyl-5-hydroxy-9-morpholino-7H-benzo[C]fluorene; intermediates for preparing indeno-fused naphthopyrans exhibiting reversible photochromism |
| 03/05/2009 | US20090062325 Deuterium-enriched tiotropium |
| 03/05/2009 | US20090062324 Catecholamine derivatives and prodrugs thereof |
| 03/05/2009 | US20090062322 Novel Tricyclic Spiropiperidines or Spiropyrrolidines |
| 03/05/2009 | US20090056793 Benzoterrylene derivatives |
| 03/05/2009 | CA2696799A1 Piperidine derivative |
| 03/05/2009 | CA2696609A1 Therapeutic isoxazole compounds |
| 03/05/2009 | CA2691961A1 Catecholamine derivatives and prodrugs thereof |
| 03/04/2009 | EP2030969A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 03/04/2009 | EP2029583A1 New benzothiazinone derivatives and their use as antibacterial agents |
| 03/04/2009 | EP2029551A2 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/04/2009 | EP2029503A1 11c/18 f-labeled inhibitors of glycogen synthase kinase-3 |
| 03/04/2009 | EP2029175A2 Fermentation and purification of actinomadura chromoprotein and related species |
| 03/04/2009 | EP1453507B1 Solubilized topoisomerase poison agents |
| 03/04/2009 | EP1380306B1 Remedies for restless leg syndrome |
| 03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
| 03/04/2009 | EP1123099B1 Novel indenoisoquinolines as antineoplastic agents |
| 03/04/2009 | CN101379044A Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 03/04/2009 | CN101378752A 4-acylaminopyridine derivative mediated neurogenesis |
| 03/04/2009 | CN101376659A Method for purifying camptothecine and derivative thereof |
| 03/04/2009 | CN101376658A 7-position cycloalkyl substituted camptothecine derivative, synthetic method and use thereof |
| 03/04/2009 | CN100465177C An oxygen, nitrogen heterocyclic naphthoyl imine kind compound and a biological application thereof |
| 03/04/2009 | CN100465175C A 7-bit substituted comptothecine kind compound and a pharmaceutical use thereof |
| 03/04/2009 | CN100465163C Cis-2,4,5-triaryl-imidazolines |
| 03/03/2009 | US7498439 Synthesis of heteroaryl acetamides from reaction mixtures having reduced water content |
| 03/03/2009 | US7498438 Fused ring NK1 antagonists |
| 03/03/2009 | US7498342 Compounds modulating c-kit activity |
| 03/03/2009 | US7498340 Topoisomerase I inhibitors; improved stability, water solubility, toxicity; anticancer agents; camptothecins bearing an oxime group in position 7; 7-tert-butoxyiminomethyl-20-O-(4-trimethyl-ammonium-3-hydroxy)butanoyl-camptothecin bromide; glioma |